Document is current
Any future updates will be listed below
-
Authors
Miyamoto, Kazutaka
Jones, Xaviar M.
Yamaguchi, Shukuro
Ciullo, Alessandra
Li, Chang
Coto, Joshua Godoy
Tsi, Kara
Anderson, Jessica
Morris, Ashley
Marbán, Eduardo
Ibrahim, Ahmed Gamal-Eldin https://orcid.org/0000-0002-1657-7432
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL124074, 142579, T32 HL116273)
California Institute of Regenerative Medicine (DISC2-13009)
Cedars-Sinai Medical Center
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 15 December 2024
Accepted: 16 December 2024
First Online: 31 December 2024
Declarations
:
: E.M. owns founder’s equity, and AGI owns stock, in Capricor Therapeutics, a company with no licensing rights to TY1 or related discoveries. Other authors declare no competing interests.
